Adamas Pharmaceutical Inc. (ADMS)

[sorkin]

"Gocovri" is age old generic medicine "Amantadine " in a new package/name. Generic Amantadine has been in clinical use in Parkinson's for years. Only thing is getting official FDA indication for he use.

This however this FDA event doesn't prevent the physicians from continuing use of "generic" Amantadine for Parkinson's.

Company have to buy generic amantadine from another company, repackage it with Gocovri label and sell it and also have to compete with the same generic drug maker!
How cool is that.

I will not be surprised if pps loses all of it's 40% gain. Also with negative cash flow secondary offerings will be in the making ( $15 pps at the best, 10% discount added). That's how Wall Street underwriters/ bankers make money.